切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (03) : 338 -344. doi: 10.3877/cma.j.issn.1673-5250.2023.03.014

论著

高脂诱导孕鼠血清及胎盘组织脂肪酸结合蛋白-4及相关脂蛋白水平变化及其意义
匡德凤1, 李志国1, 华绍芳1, 薛凤霞2,()   
  1. 1天津医科大学第二医院产科,天津 300211
    2天津医科大学总医院妇产科,天津 300052
  • 收稿日期:2022-12-17 修回日期:2023-05-08 出版日期:2023-06-01
  • 通信作者: 薛凤霞

Levels and significance of fatty acid-binding protein 4 in serum and placental tissues and related lipid protein expression of high-fat-induced pregnant rats

Defeng Kuang1, Zhiguo Li1, Shaofang Hua1, Fengxia Xue2,()   

  1. 1Department of Obstetrics, Second Hospital of Tianjin Medical University, Tianjin 300211, China
    2Department of Obstetrics and Gynecology, General Hospital of Tianjin Medical University, Tianjin 300052, China
  • Received:2022-12-17 Revised:2023-05-08 Published:2023-06-01
  • Corresponding author: Fengxia Xue
  • Supported by:
    Youth Fund of the Second Hospital of Tianjin Medical University(2019ydey20)
引用本文:

匡德凤, 李志国, 华绍芳, 薛凤霞. 高脂诱导孕鼠血清及胎盘组织脂肪酸结合蛋白-4及相关脂蛋白水平变化及其意义[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 338-344.

Defeng Kuang, Zhiguo Li, Shaofang Hua, Fengxia Xue. Levels and significance of fatty acid-binding protein 4 in serum and placental tissues and related lipid protein expression of high-fat-induced pregnant rats[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 338-344.

目的

探讨孕期脂代谢异常疾病高脂血症(HLP)的发病机制及可能的关键因子。

方法

选择50只Wistar雌性大鼠和16 Wistar雄性大鼠进行适应性饲养7 d后,按照雌、雄比例为1∶1,于傍晚进行合笼,获取优先受孕成功的孕鼠40只为研究对象。采用随机数字表法,将其平均分为2组进行不同方式饲养,高脂组(n=20,采用高脂饲料喂养)和对照组(n=20,采用普通饲料喂养)。采用全自动生化仪检测2组孕鼠胎盘组织血清脂肪酸结合蛋白(FABP)-4及血脂指标,包括总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、极低密度脂蛋白(VLDL)、动脉硬化指数T。测量2组孕鼠胎盘面积及称量胎盘重量,采用苏木精-伊红(HE)染色观察胎盘脂质沉积、滋养细胞浸润、螺旋动脉改变情况;实时荧光定量聚合酶链式反应(RT-PCR)检测胎盘组织FABP-4与脂滴相关蛋白(perilipin)A、B、C、D mRNA相对表达水平。实验过程对动物的处置符合动物伦理学要求。

结果

①高脂组孕鼠的胎盘面积及胎盘重量均大于、高于对照组,2组分别比较,差异有统计学意义(t=-4.44、-1.93,P=0.043、0.018)。②高脂组孕鼠血清FABP-4、TC、TG水平均高于对照组,而HDL水平则低于对照组,组间比较,差异亦有统计学意义(t=-11.06、-17.81、-15.28、2.48,P=0.024、0.010、0.010、0.002)。③2组孕鼠血清FABP-4水平与血清TC、TG水平呈正相关关系(r=0.827、0.818,P<0.001),与HDL水平呈负相关关系(r=-0.426,P=0.006)。④胎盘组织HE染色结果示:对照组胎盘组织未见明显脂肪细胞浸润,血管结构完整,无炎症细胞入侵;高脂组孕鼠胎盘组织中细胞质及小动脉周围存在明显空泡状脂肪细胞浸润、血管内膜纤维性增厚、管腔狭窄及管壁纤维素样坏死,并可见脂质细胞和炎性细胞浸润。⑤RT-PCR结果显示,高脂组孕鼠胎盘组织中FABP-4与perilipin A、B、C mRNA相对表达水平,均较对照组显著降低,组间比较,差异均有统计学意义(t=10.72、18.68、9.21、55.39,P=0.009,0.001、0.001、<0.001)。

结论

Wistar大鼠高脂饮食摄入,会下调胎盘组织相关脂蛋白表达,导致胎盘脂肪酸转运异常,进而出现胎盘脂质沉积、螺旋动脉改变,并引发炎症反应,导致胎盘功能或结构异常,最终导致母儿不良妊娠结局。FABP-4作为特殊的脂肪因子参与胎盘滋养细胞脂质代谢,可能作为评估胎盘功能的新手段。

Objective

To investigate changes and significance of fatty acid-binding protein (FABP)-4 in serum and placental tissues and related lipid protein expression of high-fat induced pregnant rats.

Methods

A total of 50 Wistar female rats and 16 Wistar male rats were combined in cages at night according to the ratio of female to male of 1∶1 after 7 days of adaptive feeding. After successful fertilization, 40 pregnant rats were selected and divided into high-fat group (n=20, high-fat diet) and control group (n=20, ordinary diet) by random number table method. Serum FABP-4 and blood lipid levels, including total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL) and arteriosclerosis index Twere measured by automatic biochemical analyzer between 2 groups. The placental area and weight were measured in pregnant rats. Placental lipid deposition, trophoblast infiltration, and spiral artery changes were observed by hematoxylin-eosin (HE) staining. The mRNA relative expression levels of FABP-4, lipid drop related protein(perilipin) A, B, C and D in placental tissues were determined by real time-quantitative polymerase chain reaction (RT-PCR). The disposal of animals during the experiments was in accordance with the requirements of animal ethics.

Results

①The placenta weight and placenta area of high-fat group were higher than those in control group, and there were statistical differences (t=-4.44, -1.93; P=0.043, 0.018). ②The serum levels of FABP-4、TC、TG of pregnant rats in high-fat group were higher than those in control group, while serum level of HDL was lower, and the above differences were statistically significant (t=-11.06, -17.81, -15.28, 2.48; P=0.024, 0.010, 0.010, 0.002). ③The serum level of FABP-4 was positively correlated with serum TC and TG levels (r=0.827, 0.818; P<0.001) and negatively correlated with HDL level (r= 0.426, P=0.006). ④The results on placenta tissue by HE staining showed that there was no obvious adipocyte infiltration in the placental tissue of control group, the vascular structure was intact, and there was no inflammatory cell invasion. In the placental tissue of pregnant rats in the high-fat group, there were obvious vacuolar adipocytes infiltrating, the vascular intima fibrous thickened lumen stenosis and cellline-like necrosis of the tube wall around the cytoplasm and arterioles, and the infiltration of lipid and inflammatory cells were observed. ⑤RT-PCR results showed that the relative expression levels of FABP-4, perilipin A, B and C mRNA in placental tissues of high-fat group were significantly lower than those in control group, and the differences between 2 groups were statistically significant (t=10.72, 18.68, 9.21, 55.39; P=0.009, 0.001, 0.001, 0.001).

Conclusions

During pregnancy, high-fat intake in Wistar rats can down-regulate the expression of placenta-related lipoproteins, resulting in abnormal fatty acid transport in placenta and the placental lipid deposition, arterial changes, triggering inflammatory responses, abnormal placental function or structure, and ultimately leading to adverse perinatal outcomes; FABP-4, as a special adipokines, is involved in the lipid metabolism of placental trophoblast cells, and it may be used as a new means to evaluate placental function through its dynamic monitoring;

表1 2组孕鼠胎盘面积及胎盘重量比较(±s)
表2 2组孕鼠血脂水平及血清FABP-4比较(±s)
表3 2组孕鼠血清FABP-4与各血脂指标水平的相关性分析
图2 2组孕鼠孕龄为第20天时,胎盘组织螺旋动脉改变情况(HE染色,高倍镜)(图2A:高脂组孕鼠胎盘组织中细胞质及小动脉周围存在明显空泡状脂肪细胞浸润、血管内膜纤维性增厚、管腔狭窄及管壁纤维素样坏死,并可见脂质细胞和炎性细胞浸润,蓝色箭头所示为脂质细胞浸润,绿色箭头所示为纤维素样坏死,黑色箭头所示为炎性细胞浸润;图2B:对照组孕鼠胎盘组织血管结构完整)
表4 2组孕鼠胎盘组织FABP-4及相关脂蛋白相对表达水平比较
[1]
Karr S. Epidemiology and management of hyperlipidemia [J]. Am J Manag Care, 2017, 23(9 Suppl): S139-S148.
[2]
Hutcheon JA, Stephansson O, Cnattingius S, et al. Pregnancy weight gain before diagnosis and risk of preeclampsia: a population-based Cohort study in Nulliparous women [J]. Hypertension, 2018, 72(2): 433-441. DOI: 10.1161/HYPERTENSIONAHA.118.10999.
[3]
MacDonald SC, Bodnar LM, Himes KP, et al. Patterns of gestational weight gain in early pregnancy and risk of gestational diabetes mellitus [J]. Epidemiology, 2017, 28(3): 419-427. DOI: 10.1097/EDE.0000000000000629.
[4]
Zhou Y, Peng H, Xu H, et al. Maternal diet intervention before pregnancy primes offspring lipid metabolism in liver [J]. Lab Invest, 2020, 100(4): 553-569. DOI: 10.1038/s41374-019-0344-4.
[5]
Sun X, Shen J, Wang L. Insights into the role of placenta thickness as a predictive marker of perinatal outcome [J]. J Int Med Res, 2021, 49(2): 300060521990969. DOI: 10.1177/0300060521990969.
[6]
Sun X, Shen J, Wang L. Insights into the role of placenta thickness as a predictive marker of perinatal outcome [J]. J Int Med Res, 2021, 49(2): 300060521990969. DOI: 10.1177/0300060521990969.
[7]
Vişan V, Balan RA, Costea CF, et al. Morphological and histopathological changes in placentas of pregnancies with intrauterine growth restriction [J]. Rom J Morphol Embryol, 2020, 61(2): 477-483. DOI: 10.47162/RJME.61.2.17.
[8]
Hulme CH, Nicolaou A, Murphy SA, et al. The effect of high glucose on lipid metabolism in the human placenta [J]. Sci Rep, 2019, 9(1): 14114. DOI: 10.1038/s41598-019-50626-x.
[9]
Unek G, Ozmen A, Isenlik BS, et al. The proliferation mechanism of normal and pathological human placentas [J]. Histol Histopathol, 2017, 32(4): 339-349. DOI: 10.14670/HH-11-832.
[10]
Wang C, Kong L, Yang Y, et al. Recommended reference values for serum lipids during early and middle pregnancy: a retrospective study from China [J]. Lipids Health Dis, 2018, 17(1): 246. DOI: 10.1186/s12944-018-0885-3.
[11]
Boeldt DS, Bird IM. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia [J]. J Endocrinol, 2017, 232(1): R27-R44. DOI: 10.1530/JOE-16-0340.
[12]
Hajar SS, Abbasi RZ, Alizadeh F, et al. The relationship of hyperlipidemia with maternal and neonatal outcomes in pregnancy: a cross-sectional study [J]. Int J Reprod Biomed, 2019, 17(10): 739-748. DOI: 10.18502/ijrm.v17i10.5294.
[13]
Barat S, Ghanbarpour A, Bouzari Z, et al. Triglyceride to HDL cholesterol ratio and risk for gestational diabetes and birth of a large-for-gestational-age newborn [J]. Caspian J Intern Med, 2018, 9(4): 368-375. DOI: 10.22088/cjim.9.4.368.
[14]
华绍芳,苏莉军,许丽萍. 孕期高脂摄入对雄性子代大鼠肝脏固醇调节级联通路及肝脏脂质沉积的影响[J].中华围产医学杂志2018, 21(8): 558-564. DOI: 10.3760/cma.j.issn.1007-9408.2018.08.010.
[15]
Eichelmann F, Rudovich N, Pfeiffer AF, et al. Novel adipokines: methodological utility in human obesity research [J]. Int J Obes (Lond), 2017, 41(6): 976-981. DOI: 10.1038/ijo.2017.68.
[16]
Middleton P, Gomersall JC, Gould JF, et al. Omega-3 fatty acid addition during pregnancy [J]. Cochrane Database Syst Rev, 2018, 11(11): CD003402. DOI: 10.1002/14651858.CD003402.pub3.
[17]
Herker E, Vieyres G, Beller M, et al. Lipid droplet contact sites in health and disease [J]. Trends Cell Biol, 2021, 31(5): 345-358. DOI: 10.1016/j.tcb.2021.01.004.
[18]
Morén B, Fryklund C, Stenkula K. Surface-associated lipid droplets: an intermediate site for lipid transport in human adipocytes? [J]. Adipocyte, 2020, 9(1): 636-648. DOI: 10.1080/21623945.2020.1838684.
[19]
Coleman RA. The " discovery" of lipid droplets: a brief history of organelles hidden in plain sight [J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2020, 1865(9): 158762. DOI: 10.1016/j.bbalip.2020.158762.
[20]
Keenan SN, De Nardo W, Lou J, et al. perilipin 5 S155 phosphorylation by PKA is required for the control of hepatic lipid metabolism and glycemic control [J]. J Lipid Res, 2021, 62: 100016. DOI: 10.1194/jlr.RA120001126
[21]
Gao L, Xu T, Huang G, et al. Oral microbiomes: more and more importance in oral cavity and whole body [J]. Protein Cell, 2018, 9(5): 488-500. DOI: 10.1007/s13238-018-0548-1.
[22]
Makrides M, Best K, Yelland L, et al. A randomized trial of prenatal n-3 fatty acid supplementation and preterm delivery [J]. N Engl J Med, 2019, 381(11): 1035-1045. DOI: 10.1056/NEJMoa1816832.
[23]
Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs--mechanisms and therapeutic implications [J]. Nat Rev Endocrinol, 2015, 11(10): 592-605. DOI: 10.1038/nrendo.2015.122.
[24]
Hunt CR, Ro JH, Dobson DE, et al. Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes [J]. Proc Natl Acad Sci U S A, 1986, 83(11): 3786-3790. DOI: 10.1073/pnas.83.11.3786.
[25]
Eichelmann F, Rudovich N, Pfeiffer AF, et al. Novel adipokines: methodological utility in human obesity research [J]. Int J Obes (Lond), 2017, 41(6): 976-981. DOI: 10.1038/ijo.2017.68.
[26]
Rudolph MC, Jackman MR, Presby DM, et al. Low neonatal plasma n-6/n-3 PUFA ratios regulate offspring adipogenic potential and condition adult obesity resistance [J]. Diabetes, 2018, 67(4): 651-661. DOI: 10.2337/db17-0890.
[1] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[2] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[3] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[4] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[5] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[6] 冉晨曦, 沈如飞, 廖明钰, 廖倩, 周玲, 张玉玲, 隆敏. 垂体瘤孕妇的诊治与围分娩期管理[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 487-491.
[7] 魏宇婷, 罗红. 超声弹性成像评价胎儿生长受限的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 256-260.
[8] 陈樱, 陈艳莉. 高龄孕妇心率变异性原因及围产结局分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 295-301.
[9] 冯丹艳, 曹晓辉, 史玉霞. 血清脂联素与胎盘亮氨酸氨肽酶对妊娠期糖尿病患者妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 302-308.
[10] 邬龙海, 黄淼, 龚云辉, 喻云倩. 血清趋化因子在妊娠期糖尿病孕妇中的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 357-362.
[11] 许磊, 孙杰, 陈先志, 张家泉, 李旺勇, 冯其柱, 王琦. 血液净化治疗在高血脂性重症胰腺炎中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 464-468.
[12] 刘雪云, 范颖, 姚爱军, 张胜苗, 吕亚妮, 张冰清, 张晓宇, 刘恒. 基于微信小程序的个体化、全程护理干预对孕妇孕期体重及分娩结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 455-460.
[13] 中国医师协会妇产科分会母胎医学专委会, 中华医学会围产医学分会重症学组. 预防性介入治疗在胎盘植入性疾病的应用专家共识(2023)[J]. 中华产科急救电子杂志, 2023, 12(03): 133-140.
[14] 陈颖, 曾万江. 病理组织学诊断在胎盘植入性疾病中的作用和意义[J]. 中华产科急救电子杂志, 2023, 12(03): 143-146.
[15] 赵先兰, 周艳. 胎盘植入性疾病出血血管介入治疗策略[J]. 中华产科急救电子杂志, 2023, 12(03): 147-150.
阅读次数
全文


摘要